ARCHIVES

ACCC Comments On DRGs to Be Review By PROPAC

This article is from The Cancer Letter archive.

Vol. 11 No. 34 | September 6, 1985

Download PDF Visit The Full Archive

Related Articles

Cancer Control Emphasis Shift to Prevention Projected For Y 1978; Advisors Seek More

July 29, 1977

Low Adiponcetin Hormone Levels Linked to Increased Cancer Risk

January 25, 2013

As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study

November 21, 2014

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

Controversy Continues, Scientists, Advocates, Clinicians Say

January 31, 1997

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

September 3, 1976